Latest Neuroblastoma Stories
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy.
CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
Chemotherapy is not as beneficial to young children when it comes to fighting certain forms of cancer as previously thought.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years.
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
Using immunotherapyâ€”biologic agents that stimulate the bodyâ€™s immune systemâ€”pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma.
-- New Standard of Care in High-Risk Neuroblastoma Seen in Immunotherapy Results-- PHILADELPHIA, Sept.
All amounts are in U.S. dollars QUEBEC CITY, Aug. 12 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc.
QUEBEC CITY, July 14 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc.
NEW YORK, July 14 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that KRX-0401 (perifosine) has received Orphan Drug designation from the U.S.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.